XML 20 R8.htm IDEA: XBRL DOCUMENT v3.22.2
Consolidated Statement of Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Treasury Stock
Capital in Excess of Par Value
Retained Earnings [Member]
Accumulated Other Comprehensive Income
Noncontrolling Interest
Balance at beginning of period at Dec. 31, 2020 $ 1,752,621 $ 174,792 $ (4,075) $ 981,934 $ 560,731 $ 39,366 $ (127)
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]              
Comprehensive income 233,960 0 0 0 228,879 5,005 76
Dividends, Common Stock (35,568) 0 0 0 35,568 0 0
Stock option exercises 2,364 99 0 2,265 0 0 0
Restricted stock awards, net of forfeitures 0 163 0 (163) 0 0 0
Employee share-based compensation earned 3,500 0 0 3,500 0 0 0
Purchase of Company common stock $ (106,217) $ 0 $ (2,142) $ (12,304) $ (91,771) $ 0 $ 0
Treasury Stock, Shares, Retired 0 3 3 0 0 0 0
Balance at end of period at Mar. 31, 2021 $ 1,850,660 $ 175,051 $ (6,214) $ 975,232 $ 662,271 $ 44,371 $ (51)
Balance at beginning of period at Dec. 31, 2020 1,752,621 174,792 (4,075) 981,934 560,731 39,366 (127)
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]              
Comprehensive income 398,683            
Balance at end of period at Jun. 30, 2021 1,918,111 175,725 (7,756) 984,791 714,073 51,305 (27)
Balance at beginning of period at Mar. 31, 2021 1,850,660 175,051 (6,214) 975,232 662,271 44,371 (51)
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]              
Comprehensive income 164,723 0 0 0 157,705 6,934 84
Dividends, Common Stock (35,352) 0 0 0 35,352 0 0
Stock option exercises 13,972 644 0 13,328 0 0 0
Restricted stock awards, net of forfeitures 0 (3) 0 3 0 0 0
Employee share-based compensation earned 3,596 0 0 3,596 0 0 0
Purchase of Company common stock (81,048) 0 (1,542) (8,955) (70,551) 0 0
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 60 0 0 0 0 0 60
Other (1,620) (33) 0 (1,587) 0 0 0
Balance at end of period at Jun. 30, 2021 1,918,111 175,725 (7,756) 984,791 714,073 51,305 (27)
Balance at beginning of period at Dec. 31, 2021 1,909,449 166,822 (3,708) 979,096 727,021 40,214 4
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]              
Comprehensive income 226,846 0 0 0 219,513 7,279 54
Dividends, Common Stock $ (39,964) 0 0 0 (39,964) 0 0
Dividends declared per share $ 250            
Stock option exercises $ 272 7 0 265 0 0 0
Restricted stock awards, net of forfeitures 0 147 0 (147) 0 0 0
Employee share-based compensation earned 3,687 0 0 3,687 0 0 0
Purchase of Company common stock (256,355) 0 (4,104) (24,613) (227,638) 0 0
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 162 0 0 0 0 0 162
Other 1,127 0 0 1,127 0 0 0
Balance at end of period at Mar. 31, 2022 1,842,646 166,976 (7,812) 957,161 678,932 47,493 (104)
Balance at beginning of period at Dec. 31, 2021 1,909,449 166,822 (3,708) 979,096 727,021 40,214 4
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]              
Comprehensive income 346,125            
Balance at end of period at Jun. 30, 2022 1,839,583 167,576 (9,357) 968,455 679,052 33,627 230
Balance at beginning of period at Mar. 31, 2022 1,842,646 166,976 (7,812) 957,161 678,932 47,493 (104)
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]              
Comprehensive income 119,279 0 0 0 132,670 (13,866) 475
Dividends, Common Stock $ (39,663) 0 0 0 (39,663) 0 0
Dividends declared per share $ 250            
Stock option exercises $ 15,925 574 0 15,351 0 0 0
Restricted stock awards, net of forfeitures 0 2 0 (2) 0 0 0
Employee share-based compensation earned 3,713 0 0 3,713 0 0 0
Purchase of Company common stock (103,759) 0 (1,545) (9,327) (92,887) 0 0
Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders 141 0 0 0 0 0 141
Other (1,583) (24) 0 (1,559) 0 0 0
Balance at end of period at Jun. 30, 2022 $ 1,839,583 $ 167,576 $ (9,357) $ 968,455 $ 679,052 $ 33,627 $ 230